Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study.
Nakase H, Danese S, Reinisch W, Ritter T, Liang Y, Wendt E, Levesque BG, Yoon OK, Tian Y, Zhuo L, Karouzakis E, Bauer Y, Oortwijn A, Kaise T, Malkov VA, Hibi T.
Nakase H, et al. Among authors: kaise t.
Inflamm Bowel Dis. 2024 Dec 4:izae278. doi: 10.1093/ibd/izae278. Online ahead of print.
Inflamm Bowel Dis. 2024.
PMID: 39656830